Clinical significance in COPD patients followed in a real practice

Mattioli1885 - 2013
Júlio César Mendes de Oliveira1,2, Isabella de Carvalho Aguiar2, Ana Carolina Negrinho de Oliveira Beloto2,1, Israel Reis Santos2, Fernando Sergio Studart Leitão Filho3, Luciana M Malosa Sampaio2, Claudio F Donner4, Luís Vicente Franco de Oliveira2
1Institute of the Lung, Cascavel, Brazil
2Rehabilitation Sciences Master and Doctoral Degree Program - Nove de Julho University, UNINOVE, Sao Paulo, Brazil
3Respiratory Division of Medicine School, Fortaleza University, UNIFOR, Fortaleza, Brazil
4Mondo Medico, Multidisciplinary and Rehabilitation Outpatient Clinic, Borgomanero, Italy

Tóm tắt

Chronic obstructive pulmonary disease (COPD) is an important public health issue in many countries which is estimated to become the fifth cause of disability and the third cause of mortality in the world within 2020. The objective of this study was to identify the clinical characteristics in the real clinical practice of a sample of patients with COPD followed in a pulmonology clinic. The initial sample contained 207 subjects with respiratory claims that searched for specialized treatment and initiated regular monitoring between 2004 and 2009 in a private clinic localized in Cascavel, in the state of Parana, Brazil. Demographic data (weight, height, body mass index - BMI), history of comorbidities, use of respiratory and non respiratory drugs were also registered. The main cause related to the development of COPD was current or prior smoking (92.0%); the most frequently reported symptom was dyspnea (95.0%), followed by cough (86.1%), wheezing (69.4%) and sputum production (40.0%). During the follow up, 51 patients developed the need for oxygen therapy (28.3%). In 96 patients, there were periods of acute exacerbation, resulting in 37 hospitalizations. In addition to COPD, a significant number of comorbidities were identified, being cardiovascular disease and neurological disorders the most prevalent ones. Based on the data collected, we could outline the profile of patients with COPD, showing characteristics of an elderly population, with multiple comorbidities, suggesting a health related quality of life lower than expected.

Từ khóa


Tài liệu tham khảo

Jemal A, Ward E, Hao YA, Thun M: Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005, 294 (10): 1255-1259. 10.1001/jama.294.10.1255.

Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2008, Bethesda: NHLBI/WHO workshop report, [updated 2013; cited 2013 03/21/2013]; Available from: http://www.goldcopd.com

Chapman KR, Mannino DM, Soriano JB, Vermeine PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R: Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006, 27: 188-207. 10.1183/09031936.06.00024505.

Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532. 10.1183/09031936.06.00124605.

Menezes AM, Lopez MV, Hallal PC, Muino A, Perez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, de Oca MM, Tálamo C, Victora CG, PLATINO Team: Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health. 2009, 9: 151-10.1186/1471-2458-9-151.

Peña VS, Miravitlles M, Gabriel R, Jiménez-Ruiz CA, Villasante C, Masa JF, Viejo JL, Fernández-Fau L: Geographical variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000, 118: 981-989. 10.1378/chest.118.4.981.

Kim DS, Kim YS, Jung K-S, Chang JH, Lim CM, Lee JH, Uh ST, Shim JJ, Lew WJ, Korean Academy of Tuberculosis and Respiratory Diseases: revalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005, 172: 842-847. 10.1164/rccm.200502-259OC.

Wang Y-C, Lin J-M, Li C-Y, Lee LT, Guo YL, Sung FC: Prevalence and risks of chronic airway obstruction. A population cohort study. Chest. 2007, 131: 705-710.

Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A, Kuriyama T, Takahashi K, Nishimura K, Ishioka S, Aizawa H, Zaher C: COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004, 9: 458-465. 10.1111/j.1440-1843.2004.00637.x.

Menezes AM, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG, PLATINO Team: Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005, 366: 1875-1881. 10.1016/S0140-6736(05)67632-5.

Buist AS, McBurnie MA, Vollmer WM, William M, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E, BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007, 370: 741-750. 10.1016/S0140-6736(07)61377-4.

De Miguel J, Izquierdo Alonso JL, Rodríguez G-M, de Lucas Ramos P, Molina Paris J: Tratamiento farmacológico de la EPOC en dos niveles asistenciales. Grado de adecuación a las normativas recomendadas. Arch Bronconeumol. 2003, 39: 195-202.

Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabriel R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V: Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med. 2005, 99: 985-995. 10.1016/j.rmed.2005.01.012.

Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeine PA, Vestbo J: Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J. 2002, 20: 799-805. 10.1183/09031936.02.03242002.

Roche N, Lepage T, Bourcereau J, Terrioux P: Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2001, 18: 903-908. 10.1183/09031936.01.00213701.

Jardim JR, de Oliveira JC, Nascimento O: II Consenso Brasileiro sobreDoençaPulmonarObstrutivaCrônica - DPOC. J Bras Pneumol. 2004, 30 (S. 5): 9-41.

Miravitlles M, Murio C, Tirado-Conde G, Levy G, Muellerova H, Soriano JB, Ramirez-Venegas A, Ko FW, Canelos-Estrella B, Giugno E, Bergna M, Chérrez I, Anzueto A: Geographic differences in clinical characteristics and management of COPD: the EPOCA study. Int J Chron Obstruct Pulmon Dis. 2008, 3 (4): 803-814.

Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999, 54 (7): 581-586. 10.1136/thx.54.7.581.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J. 2005, 26 (2): 319-338. 10.1183/09031936.05.00034805.

Esteban C, Moraza J, Quintana JM, Aburto M, Capelastegui A: Use of medication and quality of life among patients with COPD. Respir Med. 2006, 100: 487-495. 10.1016/j.rmed.2005.06.005.

Viejo-Banuelos JL, Pueyo-Bastida A, Fueyo-Rodriguez A: Characteristics of outpatients with COPD in daily practice: The E4 Spanish project. Respir Med. 2006, 100 (12): 2137-2143. 10.1016/j.rmed.2006.03.043.

Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL: Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989–2003). Bull World Health Organ. 2007, 85 (7): 527-534. 10.2471/BLT.06.039073.

Santos SR, Goncalves MS, LeitaoFilho FS, Jardim JR: Profile of smokers seeking a smoking cessation program. J Bras Pneumol. 2008, 34 (9): 695-701.

Nascimento OA, Camelier A, Rosa FW, Menezes AM, Perez-Padilla R, Jardim JR: Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res. 2007, 40 (7): 887-895. 10.1590/S0100-879X2006005000133.

Herland K, Akselsen JP, Skjonsberg OH, Bjermer L: How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?. Respir Med. 2005, 99 (1): 11-19. 10.1016/j.rmed.2004.03.026.

Horvathova H, Kimlikova K, Balazovjech I, Kyselovic I: Compliance and the therapeutic effect in patients with arterial hypertension. BratislLekListy. 2003, 104 (4–5): 149-154.

Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW: Heart failure and chronic obstructive pulmonary disease: An ignored combination?. Eur J Heart Fail. 2006, 8 (7): 706-711. 10.1016/j.ejheart.2006.01.010.

Schneider C, Jick SS, Bothner U, Meier CR: Chronic obstructive pulmonary disease and the risk of depression. Chest. 2010, 137 (2): 341-347. 10.1378/chest.09-0614.

Rubinstein AL, Irazola VE, Bazanno LA, Sobrino E, Calandrelli M, Lanas F, Lee AG, Manfredi JA, Olivera H, Ponzo J, Seron P, He J: Detection and follow-up of chronic obstructive pulmonary disease (COPD) and risk factors in the Southern Cone of Latin America: the pulmonary risk in South America (PRISA) study. BMC Pulm Med. 2011, 11 (34): 1471-1476.

Thông tin
Thông tin xuất bản

Mattioli1885

Thông tin tác giả